Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study

BACKGROUND: The recommendations in several countries to stop using the ChAdOx1 vaccine has led to vaccine programs combining different Coronavirus Disease 2019 (COVID-19) vaccine types, which necessitates knowledge on vaccine effectiveness (VE) of heterologous vaccine schedules. The aim of this Dani...

Descripción completa

Detalles Bibliográficos
Autores principales: Gram, Mie Agermose, Nielsen, Jens, Schelde, Astrid Blicher, Nielsen, Katrine Finderup, Moustsen-Helms, Ida Rask, Sørensen, Anne Katrine Bjørkholt, Valentiner-Branth, Palle, Emborg, Hanne-Dorthe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726493/
https://www.ncbi.nlm.nih.gov/pubmed/34919548
http://dx.doi.org/10.1371/journal.pmed.1003874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726493/
https://www.ncbi.nlm.nih.gov/pubmed/34919548
http://dx.doi.org/10.1371/journal.pmed.1003874

Ejemplares similares